shortagewatch

Home / Companies / Doc Generici

Company family

Doc Generici: medicine shortages

As of 2 Nov 2026, 50 Doc Generici products have a reported shortage across 1 countries, covering 25 medicines.

Products short50rank #36 of 464
Medicines25active ingredients
Countries1/16
New in 90 days12-11 vs market pace
Typical duration7 monthsmedian so far
Manufacturing84%demand-driven 14%

Where

Italy50

Which therapeutic classes

Nervous system19Cardiovascular system12Digestive tract and metabolism11Musculoskeletal system5Respiratory system2Cancer and immune system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Doc GenericiDoc Generici: Manufacturing problem 42 (84%)84%Doc Generici: Increased demand 7 (14%)14%Doc Generici: Regulatory or licensing 1 (2%)All companiesAll companies: Manufacturing problem 4,896 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,220 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

4950505131 Oct2026-10-31: 501 Nov2026-11-01: 502 Nov2026-11-02: 50

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

05101520Dec: 1Jan ’25: 5Feb: 1FebMar: 3Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 2NovDec: 0Jan ’26: 2Feb: 1FebMar: 4Apr: 0May: 5MayJun: 2Jul: 5Aug: 11AugSep: 1Oct: 0Nov: 0Nov

Against its peers

Viatris995Teva903Sandoz603Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Doc Generici50

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 603 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 150 / 73Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Doc Generici: 50 / 25Doc Generici

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Quetiapine731 Dec 2024Manufacturing problem12/16
Esomeprazole431 May 2026Manufacturing problem9/16
Diosmin325 Feb 2023Manufacturing problem3/16
Metformin331 Jan 2025Manufacturing problem8/16
Nifedipine316 Jan 2026Manufacturing problem6/16
Ropinirole310 Jan 2025Manufacturing problem8/16
Topiramate330 Jun 2026Manufacturing problem8/16
Alendronic Acid214 Nov 2025Manufacturing problem7/16
Calcitriol219 Apr 2024Manufacturing problem6/16
Clozapine231 Jul 2024Manufacturing problem3/16
Diclofenac230 Jun 2026Increased demand10/16
Gemfibrozil27 Jul 2026Manufacturing problem2/16
Sumatriptan231 Jul 2026Manufacturing problem13/16
Allopurinol131 May 2026Manufacturing problem9/16
Isosorbide Mononitrate131 Aug 2026Increased demand5/16
Lisinopril and Diuretics131 Aug 2026Regulatory or licensing3/16
Magaldrate121 Oct 2022Manufacturing problem1/16
Memantine130 Nov 2025Manufacturing problem8/16
Metformin and Pioglitazone127 Mar 2026Manufacturing problem1/16
Methotrexate131 Aug 2026Manufacturing problem6/16
Metoprolol131 Aug 2026Increased demand9/16
Perindopril and Diuretics115 Sep 2026Increased demand6/16
Rupatadine131 Jul 2026Manufacturing problem3/16
Salmeterol and Fluticasone131 Jul 2026Manufacturing problem6/16
Sertraline131 Aug 2026Increased demand11/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.